2OUN | B:524-759; B:524-759 | CRYSTAL STRUCTURE OF PDE10A2 IN COMPLEX WITH AMP |
2OUP | B:524-759; B:524-759 | CRYSTAL STRUCTURE OF PDE10A |
2OUQ | B:524-759; B:524-759 | CRYSTAL STRUCTURE OF PDE10A2 IN COMPLEX WITH GMP |
2OUR | B:524-759; B:524-759 | CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A IN COMPLEX WITH CAMP |
2OUS | B:524-759; B:524-759 | CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A |
2OUU | B:524-759; B:524-759 | CRYSTAL STRUCTURE OF PDE10A2 MUTANT D674A IN COMPLEX WITH CGMP |
2OUV | B:524-759; B:524-759 | CRYSTAL STRUCTURE OF PDE10A2 MUTANT OF D564N |
2OUY | B:524-759; B:524-759 | CRYSTAL STRUCTURE OF PDE10A2 MUTANT D564A IN COMPLEX WITH CAMP. |
2WEY | B:524-759; B:524-759 | HUMAN PDE-PAPAVERINE COMPLEX OBTAINED BY LIGAND SOAKING OF CROSS-LINKED PROTEIN CRYSTALS |
2Y0J | B:514-749; B:514-749 | TRIAZOLOQUINAZOLINES AS A NOVEL CLASS OF PHOSPHODIESTERASE 10A (PDE10A) INHIBITORS, PART 2, LEAD-OPTIMISATION. |
1TAZ | A:222-445 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 1B |
1Z1L | A:655-892 | THE CRYSTAL STRUCTURE OF THE PHOSPHODIESTERASE 2A CATALYTIC DOMAIN |
1SO2 | D:798-1007; D:798-1007; D:798-1007; D:798-1007 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH A DIHYDROPYRIDAZINE INHIBITOR |
1SOJ | L:798-1007; L:798-1007; L:798-1007; L:798-1007; L:798-1007; L:798-1007; L:798-1007; L:798-1007; L:798-1007; L:798-1007; L:798-1007; L:798-1007 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 3B IN COMPLEX WITH IBMX |
2QYK | B:371-615; B:371-615 | CRYSTAL STRUCTURE OF PDE4A10 IN COMPLEX WITH INHIBITOR NPV |
1RO6 | B:233-477; B:233-477 | CRYSTAL STRUCTURE OF PDE4B2B COMPLEXED WITH ROLIPRAM (R & S) |
1RO9 | B:233-477; B:233-477 | CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH 8-BR-AMP |
1ROR | B:233-477; B:233-477 | CRYSTAL STRUCTURES OF THE CATALYTIC DOMAIN OF PHOSPHODIESTERASE 4B2B COMPLEXED WITH AMP |
1TB5 | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH AMP |
1XLX | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH CILOMILAST |
1XLZ | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH FILAMINAST |
1XM4 | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH PICLAMILAST |
1XM6 | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-MESOPRAM |
1XMU | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH ROFLUMILAST |
1XMY | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R)-ROLIPRAM |
1XN0 | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH (R,S)-ROLIPRAM |
1XOS | A:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH SILDENAFIL |
1XOT | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH VARDENAFIL |
1Y2H | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 1-(2-CHLORO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
1Y2J | B:233-477; B:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
2QYL | A:233-477 | CRYSTAL STRUCTURE OF PDE4B2B IN COMPLEX WITH INHIBITOR NPV |
3KKT | B:233-477; B:233-477 | CRYSTAL STRUCTURE OF HUMAN PDE4B WITH 5-[3-[(1S,2S,4R)-BICYCLO[2.2.1]HEPT-2-YLOXY]-4-METHOXYP HENYL]TETRAHYDRO-2(1H)-PYRIMIDINONE REVEALS ORDERING OF THE C-TERMINAL HELIX RESIDUES 502-509. |
3LY2 | H:233-477; H:233-477; H:233-477; H:233-477; H:233-477; H:233-477; H:233-477; H:233-477 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4B IN COMPLEX WITH A COUMARIN-BASED INHIBITOR |
2QYM | A:281-525 | CRYSTAL STRUCTURE OF UNLIGANDED PDE4C2 |
1MKD | L:256-500; L:256-500; L:256-500; L:256-500; L:256-500; L:256-500; L:256-500; L:256-500; L:256-500; L:256-500; L:256-500; L:256-500 | CRYSTAL STRUCTURE OF PDE4D CATALYTIC DOMAIN AND ZARDAVERINE COMPLEX |
1OYN | D:159-403; D:159-403; D:159-403; D:159-403 | CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH (R,S)-ROLIPRAM |
1PTW | D:159-403; D:159-403; D:159-403; D:159-403 | THE CRYSTAL STRUCTURE OF AMP-BOUND PDE4 SUGGESTS A MECHANISM FOR PHOSPHODIESTERASE CATALYSIS |
1Q9M | D:159-403; D:159-403; D:159-403; D:159-403 | THREE DIMENSIONAL STRUCTURES OF PDE4D IN COMPLEX WITH ROLIPRAMS AND IMPLICATION ON INHIBITOR SELECTIVITY |
1TB7 | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH AMP |
1XOM | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH CILOMILAST |
1XON | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH PICLAMILAST |
1XOQ | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ROFLUMILAST |
1XOR | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH ZARDAVERINE |
1Y2B | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
1Y2C | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
1Y2D | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-METHOXY-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
1Y2E | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 1-(4-AMINO-PHENYL)-3,5-DIMETHYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
1Y2K | B:159-403; B:159-403 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 4D IN COMPLEX WITH 3,5-DIMETHYL-1-(3-NITRO-PHENYL)-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER |
1ZKN | D:159-403; D:159-403; D:159-403; D:159-403 | STRUCTURE OF PDE4D2-IBMX |
2QYN | B:159-403; B:159-403 | CRYSTAL STRUCTURE OF PDE4D2 IN COMPLEX WITH INHIBITOR NPV |
3K4S | A:159-403 | THE STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PDE4D WITH 4-(3-BUTOXY-4-METHOXYPHENYL)METHYL-2-IMIDAZOLIDONE |
1RKP | A:612-850 | CRYSTAL STRUCTURE OF PDE5A1-IBMX |
1T9R | A:612-850 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A |
1T9S | B:612-850; B:612-850 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH GMP |
1TBF | A:612-850 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH SILDENAFIL |
1UDT | A:612-850 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH SILDENAFIL(VIAGRA) |
1UDU | B:612-850; B:612-850 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH TADALAFIL(CIALIS) |
1UHO | A:612-850 | CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 5 COMPLEXED WITH VARDENAFIL(LEVITRA) |
1XOZ | A:612-850 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH TADALAFIL |
1XP0 | A:612-850 | CATALYTIC DOMAIN OF HUMAN PHOSPHODIESTERASE 5A IN COMPLEX WITH VARDENAFIL |
3JWQ | D:612-850; D:612-850; D:612-850; D:612-850 | CRYSTAL STRUCTURE OF CHIMERIC PDE5/PDE6 CATALYTIC DOMAIN COMPLEXED WITH SILDENAFIL |
3JWR | B:612-850; B:612-850 | CRYSTAL STRUCTURE OF CHIMERIC PDE5/PDE6 CATALYTIC DOMAIN COMPLEXED WITH 3-ISOBUTYL-1-METHYLXANTHINE (IBMX) AND PDE6 GAMMA-SUBUNIT INHIBITORY PEPTIDE 70-87. |
1ZKL | A:211-448 | MULTIPLE DETERMINANTS FOR INHIBITOR SELECTIVITY OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASES |
2YY2 | B:251-487; B:251-487 | CRYSTAL STRUCTURE OF THE HUMAN PHOSPHODIESTERASE 9A CATALYTIC DOMAIN COMPLEXED WITH IBMX |
3JSI | B:251-487; B:251-487 | HUMAN PHOSPHODIESTERASE 9 IN COMPLEX WITH INHIBITOR |
3JSW | B:251-487; B:251-487 | HUMAN PDE9 IN COMPLEX WITH SELECTIVE INHIBITOR |
3K3E | B:251-487; B:251-487 | CRYSTAL STRUCTURE OF THE PDE9A CATALYTIC DOMAIN IN COMPLEX WITH (R)-BAY73-6691 |
3K3H | B:251-487; B:251-487 | CRYSTAL STRUCTURE OF THE PDE9A CATALYTIC DOMAIN IN COMPLEX WITH (S)-BAY73-6691 |
3N3Z | B:251-487; B:251-487 | CRYSTAL STRUCTURE OF PDE9A (E406A) MUTANT IN COMPLEX WITH IBMX |
3QI3 | B:251-487; B:251-487 | CRYSTAL STRUCTURE OF PDE9A(Q453E) IN COMPLEX WITH INHIBITOR BAY73-6691 |
3QI4 | B:251-487; B:251-487 | CRYSTAL STRUCTURE OF PDE9A(Q453E) IN COMPLEX WITH IBMX |